1 Min Read
* Proqr announces results for the third quarter of 2017
* Proqr Therapeutics Nv - net result for three month period ended September 30, 2017 was a EUR 10.5 million loss or EUR 0.42 per share Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.